This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Colorectal cancer is the second leading cause of cancer-related deaths in the US. In the previous work, we found that sphingosine kinase 1 (SK1)/sphingosine-1-phosphate (S1P) mediates cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) production in human colon cancer cells and colorectal cancer tissues excess SK1 protein and mRNA levels as compared to normal mucosa in an azoxymethane (AOM)-induced rodent model and human colon tumors using immunohistochemistry and real time RT-PCR. In this term, we extended these findings to investigate our hypothesis that the SK1/S1P pathway may play a pivotal role in colon carcinogenesis. We found that ethanol/dodecane delivery system penetrates S1P inside the cells and S1P regulates COX-2 promoter regions through S1P receptors and intracellular mechanism. SK1 overexpression enhanced cell growth, however, did not show colony formation on agarose and tumor growth in athymic mice. We found that SK1 deficiency significantly reduced AOM-induced aberrant crypt foci (ACF), preneoplastic lesions of colon cancers, in SK1 KO mice as compared to wild type mice. These results strongly support our hypothesis and SK1 may play a role in colon carcinogenesis. We are now ongoing the long term experiment of AOM-induced colon carcinogenesis using SK1 KO and wild type mice. In addition, we have already established tetracycline-on (tet-on) system in vitro to develop SK1 transgenic mice. In the next year, we will analyze colon cancer development in SK1 KO mice and SK1 transgenic mice, and establish role of the SK1/S1P pathway in colon carcinogenesis. We will investigate relationship between SK1/S1P and COX-2/PGE2 pathways to analyze the underlying mechanisms of this pathway in colon carcinogenesis.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
2P20RR017677-06
Application #
7610447
Study Section
Special Emphasis Panel (ZRR1-RI-5 (01))
Project Start
2007-08-01
Project End
2008-06-30
Budget Start
2007-08-01
Budget End
2008-06-30
Support Year
6
Fiscal Year
2007
Total Cost
$206,101
Indirect Cost
Name
Medical University of South Carolina
Department
Biochemistry
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Zunke, Friederike; Moise, Alexandra C; Belur, Nandkishore R et al. (2018) Reversible Conformational Conversion of ?-Synuclein into Toxic Assemblies by Glucosylceramide. Neuron 97:92-107.e10
Vila├ža, Rita; Barros, Ivo; Matmati, Nabil et al. (2018) The ceramide activated protein phosphatase Sit4 impairs sphingolipid dynamics, mitochondrial function and lifespan in a yeast model of Niemann-Pick type C1. Biochim Biophys Acta Mol Basis Dis 1864:79-88
Chen, Wei; Wang, Bo; Gruber, Jordon D et al. (2018) Acyl Carrier Protein 3 Is Involved in Oxidative Stress Response in Pseudomonas aeruginosa. Front Microbiol 9:2244
Fekry, Baharan; Jeffries, Kristen A; Esmaeilniakooshkghazi, Amin et al. (2018) C16-ceramide is a natural regulatory ligand of p53 in cellular stress response. Nat Commun 9:4149
Jin, Junfei; Lu, Zhongyang; Li, Yanchun et al. (2018) LPS and palmitate synergistically stimulate sphingosine kinase 1 and increase sphingosine 1 phosphate in RAW264.7 macrophages. J Leukoc Biol 104:843-853
Snider, Justin M; Snider, Ashley J; Obeid, Lina M et al. (2018) Probing de novo sphingolipid metabolism in mammalian cells utilizing mass spectrometry. J Lipid Res 59:1046-1057
Zhang, Ning; Valentine, Joseph M; Zhou, You et al. (2017) Sustained NF?B inhibition improves insulin sensitivity but is detrimental to muscle health. Aging Cell 16:847-858
Pulkoski-Gross, Michael J; Uys, Joachim D; Orr-Gandy, K Alexa et al. (2017) Novel sphingosine kinase-1 inhibitor, LCL351, reduces immune responses in murine DSS-induced colitis. Prostaglandins Other Lipid Mediat 130:47-56
Alexaki, Aikaterini; Clarke, Benjamin A; Gavrilova, Oksana et al. (2017) De Novo Sphingolipid Biosynthesis Is Required for Adipocyte Survival and Metabolic Homeostasis. J Biol Chem 292:3929-3939
Hao, Limin; Ben-David, Oshrit; Babb, Suzann M et al. (2017) Clozapine Modulates Glucosylceramide, Clears Aggregated Proteins, and Enhances ATG8/LC3 in Caenorhabditis elegans. Neuropsychopharmacology 42:951-962

Showing the most recent 10 out of 196 publications